These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26863329)

  • 1. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
    Smith KA; Peterson JC; Arnold PM; Camarata PJ; Whittaker TJ; Abraham MG
    Int J Neurosci; 2017 Feb; 127(2):145-153. PubMed ID: 26863329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus.
    Asif H; Craven CL; Siddiqui AH; Shah SN; Matloob SA; Thorne L; Robertson F; Watkins LD; Toma AK
    J Neurosurg; 2018 Sep; 129(3):723-731. PubMed ID: 28984521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
    Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
    Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension.
    Fields JD; Javedani PP; Falardeau J; Nesbit GM; Dogan A; Helseth EK; Liu KC; Barnwell SL; Petersen BD
    J Neurointerv Surg; 2013 Jan; 5(1):62-8. PubMed ID: 22146571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Intracranial Venous Hypertension: Toward a Better Understanding of Venous Stenosis and the Role of Stenting in Idiopathic Intracranial Hypertension.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2023 Dec; 43(4):451-463. PubMed ID: 37410913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature.
    Puffer RC; Mustafa W; Lanzino G
    J Neurointerv Surg; 2013 Sep; 5(5):483-6. PubMed ID: 22863980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
    Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension.
    Satti SR; Leishangthem L; Spiotta A; Chaudry MI
    Interv Neuroradiol; 2017 Apr; 23(2):186-193. PubMed ID: 28304207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of papilledema and visual improvement in patients with idiopathic intracranial hypertension after venous sinus stenting].
    Wang W; Jia Q; Fan YM; Li XD; Wang SB; Cheng L; Wang HG; Liang WL; Bian LZ; Tong XG
    Zhonghua Wai Ke Za Zhi; 2021 Dec; 59(12):1012-1017. PubMed ID: 34839617
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term Kinetic Papilledema Improvement After Venous Sinus Stenting in Idiopathic Intracranial Hypertension.
    Touzé R; Bonnin S; Houdart E; Nicholson P; Bodaghi B; Shotar E; Clarençon F; Lenck S; Touitou V
    Clin Neuroradiol; 2021 Jun; 31(2):483-490. PubMed ID: 32399641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
    Aguilar-Pérez M; Henkes H
    Ophthalmologe; 2015 Oct; 112(10):821-7. PubMed ID: 26400795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.
    Zehri AH; Lee KE; Kartchner J; Arnel M; Martin T; Wolfe SQ; Fargen KM
    Neuroradiol J; 2022 Feb; 35(1):86-93. PubMed ID: 34224285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular Treatment for Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: An Observational Study of Clinical Indications, Surgical Technique, and Long-Term Outcomes.
    Shields LBE; Shields CB; Yao TL; Plato BM; Zhang YP; Dashti SR
    World Neurosurg; 2019 Jan; 121():e165-e171. PubMed ID: 30248468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term patency of venous sinus stents for idiopathic intracranial hypertension.
    Ducruet AF; Crowley RW; McDougall CG; Albuquerque FC
    J Neurointerv Surg; 2014 Apr; 6(3):238-42. PubMed ID: 23585640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
    Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
    J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis.
    Shazly TA; Jadhav AP; Aghaebrahim A; Ducruet AF; Jankowitz BT; Jovin TG; Bonhomme GR
    J Neurointerv Surg; 2018 Mar; 10(3):310-314. PubMed ID: 28487359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
    Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
    Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis.
    Radvany MG; Solomon D; Nijjar S; Subramanian PS; Miller NR; Rigamonti D; Blitz A; Gailloud P; Moghekar A
    J Neuroophthalmol; 2013 Jun; 33(2):117-22. PubMed ID: 23502837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in bilateral transverse sinus pressure gradients with unilateral transverse venous sinus stenting for idiopathic intracranial hypertension.
    Larson A; Rinaldo L; Chen JJ; Cutsforth-Gregory J; Theiler AR; Brinjikji W
    J Neurointerv Surg; 2021 Feb; 13(2):187-190. PubMed ID: 32482835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.